Local surveillance of antimicrobial resistance. Synercid Resistance Surveillance Group

Bariatric surgeons' views on pre-operative factors associated with improved health-related quality of life following surgery.

Clinical obesity·2024

Weight and BMI Patterns in a Biologicals-Treated IBD Cohort.

Digestive diseases and sciences·2022

Habitual dietary fibre and prebiotic intake is inadequate in patients with inflammatory bowel disease: findings from a multicentre cross-sectional study.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2020

Performance of an algorithm-based approach to the diagnosis and management of functional gastrointestinal disorders: A pilot trial.

Neurogastroenterology and motility·2017

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.

Alimentary pharmacology & therapeutics·2017

Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis.

Alimentary pharmacology & therapeutics·2017

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

International Committee on Systematics of Prokaryotes Subcommittee on the Taxonomy of Mollicutes: minutes of the closed meeting, 6 July 2026, Kraków, Poland.

International journal of systematic and evolutionary microbiology·2026

A hyphal release-capture soil microcosm for recovering hyphosphere bacterial communities.

mSystems·2026

MiR-29a deficiency disrupts gut microbiota-bile acid homeostasis and impairs the anti-inflammatory effects of lithocholic acid in colitis.

Frontiers in cellular and infection microbiology·2026

Stannous Fluoride: NMR Characterization and Antibacterial Activity by Microbiome Analysis.

Journal of dentistry·2026

Identification and characterization of four novel gut bacterial taxa: Alvibacillus kangbaii gen. nov., sp. nov., Jutongia huiwenae sp. nov., Flintibacter aciditolerans sp. nov., and Dizhoua hominis gen. nov., sp. nov. isolated from human feces.

Systematic and applied microbiology·2026

Microfilaremic loiasis is associated with T cell hyporesponsiveness against SARS-CoV-2.

PLoS neglected tropical diseases·2026

Related Experiment Videos

Local surveillance of antimicrobial resistance. Synercid Resistance Surveillance Group

Related Concept Videos

Bariatric surgeons' views on pre-operative factors associated with improved health-related quality of life following surgery.

Weight and BMI Patterns in a Biologicals-Treated IBD Cohort.

Habitual dietary fibre and prebiotic intake is inadequate in patients with inflammatory bowel disease: findings from a multicentre cross-sectional study.

Performance of an algorithm-based approach to the diagnosis and management of functional gastrointestinal disorders: A pilot trial.

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.

Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

International Committee on Systematics of Prokaryotes Subcommittee on the Taxonomy of Mollicutes: minutes of the closed meeting, 6 July 2026, Kraków, Poland.

A hyphal release-capture soil microcosm for recovering hyphosphere bacterial communities.

MiR-29a deficiency disrupts gut microbiota-bile acid homeostasis and impairs the anti-inflammatory effects of lithocholic acid in colitis.

Stannous Fluoride: NMR Characterization and Antibacterial Activity by Microbiome Analysis.

Identification and characterization of four novel gut bacterial taxa: Alvibacillus kangbaii gen. nov., sp. nov., Jutongia huiwenae sp. nov., Flintibacter aciditolerans sp. nov., and Dizhoua hominis gen. nov., sp. nov. isolated from human feces.

Microfilaremic loiasis is associated with T cell hyporesponsiveness against SARS-CoV-2.

Related Experiment Videos

Local surveillance of antimicrobial resistance. Synercid Resistance Surveillance Group

Related Concept Videos

Related Articles